Litcius/Paper detail

ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases

Fei Luo, Avash Das, Sumeet A. Khetarpal, Zhenfei Fang, Thomas A. Zelniker, Robert S. Rosenson, Arman Qamar

2023Trends in Cardiovascular Medicine55 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePCSK9DyslipidemiaHyperlipidemiaResidual riskInternal medicineDiseaseFamilial hypercholesterolemiaDiabetes mellitusCoronary artery diseaseTriglycerideLipoproteinBioinformaticsEndocrinologyCholesterolLDL receptorBiologyLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases | Litcius